CareDx Q1 2024 Adj EPS $(0.03) Beats $(0.21) Estimate, Sales $72.049M Beat $63.140M Estimate
CareDx Q1 2024 Adj EPS $(0.03) Beats $(0.21) Estimate, Sales $72.049M Beat $63.140M Estimate
CaredX 2024 年第一季度经调整后每股收益 (0.03 美元) 超过预期 (0.21) 美元，销售额7,2049万美元超过预期的6,3140万美元
CareDx (NASDAQ:CDNA) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.21) by 85.71 percent. This is a 72.73 percent increase over losses of $(0.11) per share from the same period last year. The company reported quarterly sales of $72.049 million which beat the analyst consensus estimate of $63.140 million by 14.11 percent. This is a 6.75 percent decrease over sales of $77.262 million the same period last year.
CaredX（纳斯达克股票代码：CDNA）公布的季度亏损为每股0.03美元，比分析师普遍预期的0.21美元（0.21美元）高出85.71％。与去年同期的每股亏损（0.11）美元相比，增长了72.73％。该公司公布的季度销售额为7,2049万美元，比分析师普遍预期的631.4亿美元高出14.11％。这比去年同期的7,726.2万美元的销售额下降了6.75％。